James E. Dentzer

Companies

• Imunon, Inc.Board member Oct 3, 2022 to now¹
• CURIS INCBoard member Sep 27, 2018 to now²
• CURIS INCChief executive officer Sep 27, 2018 to now²
• CURIS INCPresident Sep 27, 2018 to now²
• CURIS INCChief operating officer May 17, 2018 to May 17, 2018³
• CURIS INCChief financial officer Mar 30, 2016 to May 17, 2018⁴
• Dicerna Pharmaceuticals (United States)Chief financial officer Jan 29, 2014 to Jan 13, 2015⁵
• Amicus TherapeuticsChief financial officer May 30, 2007 to Oct 1, 2009⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CCURIS INC CRIS148,730 shares⁷$60.5K at $0.41Mar 20, 2026
• IImunon, Inc. IMNN21,897 shares⁸$23.2K at $1.06Jul 31, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 31, 2026Granted 6,934 shares at $1.59 of Imunon, Inc.⁸
• May 22, 2026Granted 11,148 shares at $2.20 of Imunon, Inc.⁹
• Mar 20, 2026Converted 133,333 shares of CURIS INC⁷
• Aug 4, 2025Granted 3,318 shares at $9.20 of Imunon, Inc.¹⁰
• Jan 31, 2022Sold 3,094 shares at $3.07 of CURIS INC¹¹
• Jan 27, 2022Sold 2,406 shares at $3.18 of CURIS INC¹¹